TrialCNS drugs2025

Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON Trial.

Lois Krahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.